The drugmaker behind Wegovy has secured a major victory after the High Court granted it a blocking order for websites selling fake versions of its weight-loss jabs.

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the ...

President Donald Trump said there will Ozempic prices will be lower after negotiations with Novo Nordisk as part of his ...

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and ...

Shares of Danish pharmaceutical giant Novo Nordisk are trading lower Friday morning, continuing an after-hours slide that ...

Medically, you don’t have to taper off semaglutide, but many experts recommend it when stopping the medication. Some ...

CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, ...

Shares of weight-loss drug makers Novo Nordisk and Eli Lilly fell on Friday after U.S. President Donald Trump said that the price of Novo's popular Ozempic treatment would be lowered.

A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift ...

The price of weight-loss drugs like Ozempic and Wegovy are in the crosshairs of the Trump administration. Makers of weight-loss drugs such as Novo Nordisk were under pressure on Friday after President ...

Mehmet Oz, head of the Centers for Medicare and Medicaid Services, said talks over the price of weight-loss drugs are still ...